supplementhackr
FINAFLEX

Pure Test

Serving
6 Capsule(s)
Per container
20
Form
capsule-unknown
UPC
689466130508
DSLD
178381
Formula hash
dcee6c1a54e9
Brand context
FINAFLEX
Catalog
95
products
With avoid flag
27
products
FDA recalls
0
history
CAERS
2
reports
Caution-flaggedObjective label signals
Flagged excipients
2
0 avoid · 2 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
2 excipients carry authority-caution citations. · Every flag below links to the authority's published citation.

Supplement Facts

1 active ingredients
IngredientAmount% DV
D-Aspartic Acid, Powder
D-Aspartic Acidamino_acidUNII · 4SR0Q8YD1X
3 Gram(s)—
Flagged excipients

2 flagged · authority citations

  • ◐ CAUTIONFD&C Red #3
    color

    FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.

    fda.gov →federalregister.gov →
  • ◐ CAUTIONFD&C Yellow #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

    eur-lex.europa.eu →
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Silica · Magnesium Stearate · Stearic Acid

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.